Migdal Insurance & Financial Holdings Ltd. Heron Therapeutics, Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$2.3 - $6.29 $1,150 - $3,145	-500 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$4.63 - $9.94 $7,921 - $17,007	-1,711 Reduced 77.39%	500 $3,000
Q4 2021 Feb 02, 2022	SELL	$8.35 - $12.6 $10,095 - $15,233	-1,209 Reduced 35.35%	2,211 $21,000
Q3 2021 Nov 16, 2021	BUY	$10.13 - $15.0 $34,644 - $51,300	3,420 New	3,420 $37,000

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$42.2 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$14 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$13.8 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$13.2 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$11 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $188M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account